Results 51 to 60 of about 7,222 (160)

Crude incidence rate of outcomes for 2 doses of CoronaVac or BNT162b2 recipients and respective matched controls, and hazard ratio for 2 doses of CoronaVac or BNT162b2 recipients in comparison with their respective matched controls.

open access: yes, 2023
Crude incidence rate of outcomes for 2 doses of CoronaVac or BNT162b2 recipients and respective matched controls, and hazard ratio for 2 doses of CoronaVac or BNT162b2 recipients in comparison with their respective matched controls.
Ivan Chi Ho Au (12902264)   +15 more
core   +1 more source

One‐Year Quality of Life Among Survivors of Hospitalization for Omicron Infection in Brazil: A Multicentre Prospective Cohort Study

open access: yesJournal of Medical Virology, Volume 97, Issue 11, November 2025.
ABSTRACT The lingering effects of COVID‐19 may impair survivors' long‐term health‐related quality of life (HRQoL). However, multicentre studies focusing on the Omicron variant, particularly in middle‐ and low‐income settings, are scarce. We conducted a prospective cohort study across 24 Brazilian hospitals between December 2021 and March 2024, when ...
Geraldine Trott   +55 more
wiley   +1 more source

Evaluation and follow-up of antibody formation after CoronaVac vaccine

open access: yesRevista da Associação Médica Brasileira, 2022
The aim of this study was to monitor the time-dependent change by evaluating the antibody levels at the 4th, 7th, 10th, 13th, and 16th weeks after the second dose of the CoronaVac vaccine.The study group (n=65) were between 21 and 60 years old and received two doses of the CoronaVac vaccine.
Büşra Çalişir   +6 more
openaire   +5 more sources

ANALISIS PERBEDAAN KEJADIAN IKUTAN PASCA IMUNISASI (KIPI) VAKSIN CORONAVAC DOSIS PERTAMA DAN KEDUA PADA MASYARAKAT PROVINSI JAWA TENGAH [PDF]

open access: yes, 2022
Kejadian ikutan pasca imunisasi (KIPI) vaksin coronavac masih banyak ditemukan di Indonesia terkhusus di Provinsi Jawa Tengah. Tujuan dari penelitian ini adalah untuk mengetahui perbedaan kejadian ikutan pasca imunisasi (KIPI) vaksin coronavac dosis ...
Banin, Syifa Audina
core  

Crude incidence rate of outcomes for CoronaVac or BNT162b2 recipients, COVID-19 patients, and respective matched controls, and HR of events for CoronaVac or BNT162b2 recipients and COVID-19 patients in comparison with their respective matched controls.

open access: yes, 2023
Crude incidence rate of outcomes for CoronaVac or BNT162b2 recipients, COVID-19 patients, and respective matched controls, and HR of events for CoronaVac or BNT162b2 recipients and COVID-19 patients in comparison with their respective matched controls.
Ivan Chi Ho Au (12902264)   +15 more
core   +1 more source

Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities

open access: yes, 2023
Although humoral responses elicited by infection or vaccine lost the ability to prevent transmission against Omicron, vaccine-induced antibodies may still contribute to disease attenuation through Fc-mediated effector functions.
Lili Wang (104605)   +10 more
core   +2 more sources

SARS‐CoV‐2 Spike Protein as a Target of the COVID‐19 Vaccine Disrupts Insulin Signaling in Type 2 Diabetes

open access: yesMedComm, Volume 6, Issue 11, November 2025.
SARS Cov‐2 spike protein disrupts insulin signaling in type 2 diabetes as a target of the COVID‐19 vaccine in subject with type 2 diabetes (T2D), while metformin improved the insulin signaling variations induced by mRNA COVID‐19 vaccine boosters in mice.
Lixiang Zhai   +12 more
wiley   +1 more source

Crude incidence rate of outcomes for CoronaVac or BNT162b2 recipients, COVID-19 patients, and respective matched controls, and incidence rate ratio of events for CoronaVac or BNT162b2 recipients and COVID-19 patients in comparison with their respective matched controls.

open access: yes, 2023
Crude incidence rate of outcomes for CoronaVac or BNT162b2 recipients, COVID-19 patients, and respective matched controls, and incidence rate ratio of events for CoronaVac or BNT162b2 recipients and COVID-19 patients in comparison with their respective ...
Ivan Chi Ho Au (12902264)   +15 more
core   +1 more source

Should We Advance Our Understanding of Immunoglobulin E in Viral Immunity?

open access: yesImmunology, Volume 176, Issue 3, Page 312-321, November 2025.
Immunoglobulin E has been extensively studied in allergies and parasitic diseases. Antigen‐specific IgE has been identified as part of the humoral response to viruses. This revision speculates on possible functionalities for IgE, such as neutralisation, cytotoxicity and immunopathology of viral diseases, and provide insights about gaps to fill in ...
Amanda Izeli Portilho   +3 more
wiley   +1 more source

Minimal change disease following vaccination with CoronaVac [PDF]

open access: yesClinical Kidney Journal, 2021
Ahmet Burak Dirim   +10 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy